Management of Glucocorticoid-related Osteoporotic Vertebral Fracture

Overview

Journal Osteoporos Sarcopenia

Date 2020 Apr 1

PMID 32226826

Citations 2

Authors

Stella Pui Yan Wong

Chi Chiu Mok

Affiliations

Soon will be listed here.

Abstract

The vertebral column is the most common site of osteoporotic fractures in long-term users of glucocorticoids. Vertebral fracture leads to significant morbidities such as unrelenting pain, spinal deformities and reduced mobility, leading to diminished quality of life. Epidemiological data on the prevalence of glucocorticoid-induced vertebral fractures are limited. As vertebral fracture is a strong risk factor for further fragility fractures and mortality, it should be treated appropriately. This article reviews recent data on the prevalence of vertebral fractures in glucocorticoid users, fracture risk stratification, and evidence-based treatment options. The risk of osteoporotic fractures estimated by FRAX should be adjusted for glucocorticoid users. The first-line treatment of glucocorticoid-induced osteoporosis remains the bisphosphonates. Teriparatide and denosumab are alternative options. Percutaneous vertebroplasty and kyphoplasty may be considered for symptomatic control of acute vertebral fracture-related pain when conservative measures fail.

Citing Articles

Ukrainian guideline for the prevention and treatment of glucocorticoid-induced osteoporosis.

Grygorieva N, Kovalenko V, korzh M, Tronko M, Golovach I, Dedukh N Arch Osteoporos. 2025; 20(1):31.

PMID: 39992470 DOI: 10.1007/s11657-025-01512-9.

Oral Corticosteroids for Skin Disease in the Older Population: Minimizing Potential Adverse Effects.

Sparling K, Butler D Drugs Aging. 2024; 41(10):795-808.

PMID: 39285122 DOI: 10.1007/s40266-024-01143-8.

Epidemiology of glucocorticoid-induced osteoporosis and management of associated fracture risk in Japan.

Soen S, Kaku M, Okubo N, Touzeni S, Saito K, Kobayashi M J Bone Miner Metab. 2021; 39(6):1019-1030.

PMID: 34125296 DOI: 10.1007/s00774-021-01236-z.

References

Schousboe J . Epidemiology of Vertebral Fractures. J Clin Densitom. 2015; 19(1):8-22. DOI: 10.1016/j.jocd.2015.08.004. View

Barr J, Jensen M, Hirsch J, McGraw J, Barr R, Brook A . Position statement on percutaneous vertebral augmentation: a consensus statement developed by the Society of Interventional Radiology (SIR), American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS),.... J Vasc Interv Radiol. 2013; 25(2):171-81. DOI: 10.1016/j.jvir.2013.10.001. View

Saag K, Shane E, Boonen S, Marin F, Donley D, Taylor K . Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med. 2007; 357(20):2028-39. DOI: 10.1056/NEJMoa071408. View

Marcia S, Muto M, Hirsch J, Chandra R, Carter N, Crivelli P . What is the role of vertebral augmentation for osteoporotic fractures? A review of the recent literature. Neuroradiology. 2018; 60(8):777-783. DOI: 10.1007/s00234-018-2042-0. View

Adami G, Saag K . Glucocorticoid-induced osteoporosis update. Curr Opin Rheumatol. 2019; 31(4):388-393. DOI: 10.1097/BOR.0000000000000608. View

Kanis J, Johansson H, Oden A, McCloskey E . Guidance for the adjustment of FRAX according to the dose of glucocorticoids. Osteoporos Int. 2011; 22(3):809-16. DOI: 10.1007/s00198-010-1524-7. View

Kung A . Epidemiology and diagnostic approaches to vertebral fractures in Asia. J Bone Miner Metab. 2004; 22(3):170-5. DOI: 10.1007/s00774-003-0467-x. View

Cohen S, Levy R, Keller M, BOLING E, Emkey R, Greenwald M . Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheum. 1999; 42(11):2309-18. DOI: 10.1002/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K. View

Kallmes D, Comstock B, Heagerty P, Turner J, Wilson D, Diamond T . A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med. 2009; 361(6):569-79. PMC: 2930487. DOI: 10.1056/NEJMoa0900563. View

10.

Lin X, Xiong D, Peng Y, Sheng Z, Wu X, Wu X . Epidemiology and management of osteoporosis in the People's Republic of China: current perspectives. Clin Interv Aging. 2015; 10:1017-33. PMC: 4485798. DOI: 10.2147/CIA.S54613. View

11.

Donovan M, Khandji A, Siris E . Multiple adjacent vertebral fractures after kyphoplasty in a patient with steroid-induced osteoporosis. J Bone Miner Res. 2004; 19(5):712-3. DOI: 10.1359/JBMR.040207. View

12.

Saag K, Zanchetta J, Devogelaer J, Adler R, Eastell R, See K . Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial. Arthritis Rheum. 2009; 60(11):3346-55. DOI: 10.1002/art.24879. View

13.

Melton 3rd L, Lane A, Cooper C, Eastell R, OFallon W, Riggs B . Prevalence and incidence of vertebral deformities. Osteoporos Int. 1993; 3(3):113-9. DOI: 10.1007/BF01623271. View

14.

van Staa T, Leufkens H, Cooper C . The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int. 2002; 13(10):777-87. DOI: 10.1007/s001980200108. View

15.

Tsourdi E, Langdahl B, Cohen-Solal M, Aubry-Rozier B, Eriksen E, Guanabens N . Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS. Bone. 2017; 105:11-17. DOI: 10.1016/j.bone.2017.08.003. View

16.

Syed M, Patel N, Jan S, Shaikh A, Grunden B, Morar K . Symptomatic refractures after vertebroplasty in patients with steroid-induced osteoporosis. AJNR Am J Neuroradiol. 2006; 27(9):1938-43. PMC: 7977917. View

17.

Balasubramanian A, Wade S, Adler R, Lin C, Maricic M, OMalley C . Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis. Osteoporos Int. 2016; 27(11):3239-3249. DOI: 10.1007/s00198-016-3646-z. View

18.

Buchbinder R, Johnston R, Rischin K, Homik J, Jones C, Golmohammadi K . Percutaneous vertebroplasty for osteoporotic vertebral compression fracture. Cochrane Database Syst Rev. 2018; 4:CD006349. PMC: 6494647. DOI: 10.1002/14651858.CD006349.pub3. View

19.

Esses S, McGuire R, Jenkins J, Finkelstein J, Woodard E, Watters 3rd W . American Academy of Orthopaedic Surgeons clinical practice guideline on: the treatment of osteoporotic spinal compression fractures. J Bone Joint Surg Am. 2011; 93(20):1934-6. DOI: 10.2106/JBJS.9320ebo. View

20.

Adami G, Saag K . Glucocorticoid-induced osteoporosis: 2019 concise clinical review. Osteoporos Int. 2019; 30(6):1145-1156. DOI: 10.1007/s00198-019-04906-x. View